Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Researchers and key players operating in the market are focusing on extensive research and development activities, in order to develop and launch the novel interventional oncology ablation procedures for the treatment of cancer.

The ongoing research and development activities have made tumor ablation treatment as a safe and painless one especially due to impressive results during and after the procedure. Moreover, due to increasing awareness in the healthcare industry across the globe, cancer ablation is becoming increasingly popular for different types of cancer liver cancer kidney cancer and etc, as one of the most favored cancer therapy methods.

For instance, in December 2020, researchers from the University Of Missouri School Of Medicine discovered a treatment combination that significantly reduces tumor growth and extends the life span of mice with liver cancer in pilot study. This discovery provides a potentially new therapeutic approach to treating one of the leading causes of cancer-related death worldwide. It is an integrative therapy that combined minimally invasive radiofrequency ablation (RFA) with the chemotherapy drug sunitinib. Development of an effective sunitinib and RFA combination therapy is an important contribution to the field of liver cancer treatment and can be quickly translated into clinical applications, as both sunitinib and RFA are approved by the U.S. Food and Drug Administration (FDA) and are readily available cancer therapies.

The global interventional oncology ablation market is estimated to be valued at US$ 453.1 million in 2020 and is expected to exhibit a CAGR of 7.8% over the forecast period (2020-2027).

Figure 1. Global Interventional Oncology Ablation Market Share (%) in Terms of Value, By Region, 2020

Interventional Oncology Ablation  | Coherent Market Insights

Increasing adoption of inorganic growth strategies by the key players is expected to drive the market growth over the forecast period.

Interventional oncology ablation market is expected to offer lucrative opportunity in the near future, owing to focus of major market players on adoption of inorganic growth strategies such as acquisitions, partnerships, and agreements to strengthen their product portfolio and presence in the global market.

For instance, in January 2019, Medtronic entered into an agreement to acquire Epix Therapeutics, a company engaged in the manufacturing of catheter-based system for the treatment of patients with atrial fibrillation. The acquisition is expected to expand the company's cardiac ablation portfolio.

Moreover, in July 2018, Boston Scientific signed an agreement to acquire Cryterion Medical, a company developed single-shot cryoablation platform for the treatment of atrial fibrillation  The acquisition is expected to enable the former company in providing cryothermal, as well as radiofrequency (RF) single-shot, balloon-based ablation therapies.

request-sample

Interventional Oncology Ablation Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2020: US$ 453.1 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2020 to 2027
Forecast Period 2021 to 2027 CAGR: 7.8% 2027 Value Projection: US$ 766.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation
  • By Indication: Liver Cancer, Kidney Cancer, Lung Cancer, Others
  • By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Others
Companies covered:

Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.

Growth Drivers:
  • Increasing incidence of cancer
  • Increasing research and development activities 
Restraints & Challenges:
  • Complications associated with oncology ablation
  • High treatment cost associated with interventional oncology ablation

Figure 2. Global Interventional Oncology Ablation Market Share (%), by Technology, 2020

Interventional Oncology Ablation  | Coherent Market Insights

The increasing incidence of cancer is another major factor driving the market growth. For instance, according to the report published by European Cancer Information System in July 2020, the cancer burden is estimated to have risen to 2.7 million new cases (all types, excluding non-melanoma skin cancer) and 1.3 million deaths in 2020 in European 27 countries. Similarly, according to the same source, the 2020 estimates reveal that 62% of estimated new diagnoses and 76% of estimated deaths occurred due to cancer in people over 65 years old in EU 27 countries in 2020.

Global Interventional Oncology Ablation Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of Coronavirus (COVID-19) has resulted in more than 120 million infected individuals worldwide as of March 16, 2021.

The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries. This has led to disruption in the link between regional warehouses, and the transportation of materials between regions cannot be carried out successfully. This shortage of probes required for interventional ablation materials and components used with the interventional ablation devices have affected the supply chain of the global interventional oncology ablation market.

Moreover, the hospitals are delaying the treatments of cancer patients who are with less severity, as cancer patients are at high risk of getting infected by the COVID-19 infection, which is expected to hamper demand for interventional oncology ablation in cancer patients.

Global Interventional Oncology Ablation Market Restraint

Oncology ablation such as radiofrequency ablation (RFA) and microwave ablation can cause several side effects on patients undergoing ablation procedures.

Radiofrequency ablation (RFA) is used to treat different types of cancer effectively. However, similar to other treatments, it often causes side effects depending on the type of cancer, its location, the radiation therapy dose, and the patient’s general health.

Reported RFA treatment-related complications include pneumothorax, symptomatic pleural effusion, and bleeding from the needle track or into the treated tumor, biliary fistula, biliary stricture, biloma, abscess in the treated tumor, skin burn, cholecystitis, thermal injury to adjacent structures including the diaphragm, stomach, duodenum, and transverse colon, liver failure, segmental hepatic infarction, paralysis of the hemidiaphragm, arterial-portal venous fistula, systemic hemolysis, tumor lysis syndrome, myoglobinemia or myoglobinuria, transient acute renal failure, and prolonged post treatment pain for lesions near the hepatic capsule.

Key Players

Major players operating in the global interventional oncology ablation market include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.

Interventional oncology ablation is a minimally invasive procedure to treat solid cancers. In this procedure, special probes are used to burn or freeze cancer tumors without the usual surgery.

Market Dynamics

The increasing incidence of cancer is expected to drive the growth of global interventional oncology ablation market over the forecast period.

For instance, according to the World Health Organization statistics published in March 2021, cancer is the second leading cause of death globally and is responsible for about 10 million deaths per year, and globally about one in six deaths are due to cancer. Furthermore, according to the same source, an estimated 9.6 million deaths occurred due to cancer in 2018 globally.

Key features of the study:

  • This report provides in-depth analysis of the global interventional oncology ablation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global interventional oncology ablation market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market

Detailed Segmentation:

  • Global Interventional Oncology Ablation Market, By Technology:
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryoablation
    • Irreversible Electroporation Ablation
  • Global Interventional Oncology Ablation Market, By Indication:
    • Liver Cancer
    • Kidney cancer
    • Lung Cancer
    • Others
  • Global Interventional Oncology Ablation Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Interventional Oncology Ablation Market, By Region:
    • North America
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • Irreversible Electroporation Ablation
      • By Indication
        • Liver Cancer
        • Kidney cancer
        • Lung Cancer
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Johnson & Johnson
    • Medtronic Plc
    • Varian Medical Systems, Inc.
    • EDAP TMS S.A.
    • AngioDynamics
    • CASCINATION AG
    • Merit Medical Systems, Inc.
    • STARmed Co.
    • Biomedical Srl

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Acquisition, Collaboration, and Agreement
    • Epidemiology
    • PEST Analysis
    • Reimbursement Scenario
    • Pricing Analysis, By Procedure
  4. Global Interventional Oncology Ablation Market – Impact of Coronavirus (COVID-19) Pandemic
    • Pricing Analysis, By Procedure
    • Impact on Supply and Demand
    • Clinical Trial Impact Analysis
  5. Global Interventional Oncology Ablation Market, By Technology, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Radiofrequency Ablation
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Microwave Ablation
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cryoablation
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Irreversible Electroporation Ablation
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Interventional Oncology Ablation Market, By Indication, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Liver Cancer
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Kidney Cancer
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Lung Cancer
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Interventional Oncology Ablation Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Interventional Oncology Ablation Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Technology, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Technology, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Indication, 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By End User , 2016–2027, (US$ Million)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast Value, and Y-o-Y Growth, By Country, 2016–2027, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Market Share Analysis
      • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Johnson & Johnson
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Medtronic Plc
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Varian Medical Systems, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • EDAP TMS S.A.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AngioDynamics
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • CASCINATION AG
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Merit Medical Systems, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • STARmed Co.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Biomedical Srl
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 207 market data tables and 56 figures on "Interventional Oncology Ablation Market” - Global forecast to 2027

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users